...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith and Covid?

You may find your answer here, under Plan of Arrangement, Pages 7 and 8.

https://www.resverlogix.com/upload/media_element/48/798f19de476a/mda-resverlogix-corp-2015-04-30-2015.07.24.pdf

 

Koo

Share
New Message
Please login to post a reply